Innate Immune Cell Infiltration Induced by Polatuzumab Vedotin Contributes to the Antitumor Effect in Mouse Models
{{output}}
Introduction: Polatuzumab vedotin (Pola) is an antibody-drug conjugate approved for the treatment of diffuse large B-cell lymphoma (DLBCL). Several reports suggest that the tumor microenvironment influences the outcome of DLBCL t... ...
